5+ ITEMS = 10% OFF
EU WAREHOUSE · 24–48H DELIVERY
PLAIN BOX · ZERO BRANDING
PAY THE COURIER · NO CARD NEEDED
FREE SHIPPING OVER €85
5+ ITEMS = 10% OFF
EU WAREHOUSE · 24–48H DELIVERY
PLAIN BOX · ZERO BRANDING
PAY THE COURIER · NO CARD NEEDED
FREE SHIPPING OVER €85
Try a substance, brand, or product name…
Cart 0
€85,00 more for free shipping
No products in the cart.
Injectable Steroids
Megabol 200mg (Tren/Dbol/Test Blend)
Megabol 200mg (Tren/Dbol/Test Blend) (200 mg) — Medical Pharma presents this pharmaceutical-grade compound — this multi-compound injectable blend combines complementary anaboli...
€70,00
In Stock(100 available)
Medical Pharma · Megabol 200mg (Tren/Dbol/Test Blend) (200 mg) — Medical Pharma presents this pharmaceutical-grade compound — this multi-compound injectable blend combines complementary anaboli…
100 in stock
5+−10%
10+−15%Best price
Third-Party Lab ReportHPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
Megabol 200mg (Tren/Dbol/Test Blend) — Methandienone — the classic oral mass-builder. 17α-alkylated testosterone derivative that aromatises aggressively and delivers acute strength and scale-weight gains. Each unit dosed at 200 mg.
Key Benefits
Rapid-onset mass builder — strength and pumps within 24–48 hours
Enhanced protein synthesis, nitrogen retention, and glycogenolysis
Classic cycle kickstart — saturates while long-ester injectable ramps
Aromatises — AI management mandatory from day one
Split daily dose 2–3× for stable plasma levels
Each unit dosed at 200 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: 20–50 mg/day for 4–6 weeks. Split across 2–3 administrations per day due to the short half-life. Cycles over 6 weeks rarely justified — drop the oral and continue the injectable base. Above 50 mg/day side-effect load climbs steeply (bloat, hypertension, liver).
How It Works
17α-alkylated oral derived from testosterone by adding a 1,2-double bond. Aromatises to methylestradiol — full oestrogenic side-effect profile (gyno, water retention, potential hypertension). Strong AR binder and aggressive protein-synthesis driver. Rapid strength and mass gains — typically 4–7 kg scale weight in two weeks, much of it water.
Pharmacokinetics
Plasma half-life approximately 6 hours — one of the shortest of any oral AAS. Pre-workout dosing gives a tight training-window peak. Hepatotoxic; ALT/AST commonly 2–3× baseline at week 4. TUDCA 500 mg/day mandatory, NAC 1200 mg/day recommended.
Potential Side Effects
Oestrogenic effects (bloat, gyno risk, BP) dominate the side-effect profile. Hepatic stress noticeable by week 4. HDL crash. Suppression universal. Keep anastrozole 0.25–0.5 mg EOD on hand — dose by bloodwork, not feel.
Cycle & Stacking Guide
Classic cycle kickstart: weeks 1–4 or 1–6 alongside a long-ester injectable (test E/C) while the injectable saturates. Drop the oral, continue the injectable through week 12. Not for standalone cycles or back-to-back oral runs.
Storage & Handling
Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.
Mechanism & protocol-relevant pharmacology, reviewed by editorial pharmacology lead
C17alpha-alkylated testosterone with an added 1,2-double bond — oral bioavailability via resistance to hepatic first-pass, at the cost of hepatocellular stress. Rapid onset: serum concentrations peak within 2 h, half-life under 6 h. Split dosing (20 mg morning, 20 mg pre-training) holds steadier curves than single boluses. Aromatisation is significant and proceeds via a distinct pathway (17alpha-methylestradiol) which does not respond predictably to anastrozole — SERM (tamoxifen 10 mg/day) is the better intra-cycle gyno control tool. Classic bloat is methylestradiol water retention, not subcutaneous fluid, and dissipates within 2 weeks of cessation. ALT/AST elevation 2–4x ULN is the norm at 30–50 mg/day x 6 weeks. TUDCA 500 mg/day during oral use is non-optional.
Known trade names:
Dianabol, Danabol, Naposim, Metanabol
Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.
Mechanism & protocol-relevant pharmacology, reviewed by editorial pharmacology lead
19-nor 5alpha-reduced analogue of nandrolone. Non-aromatizable — AR-binding affinity roughly 5x testosterone, with measurable agonist activity at the progesterone receptor. The acetate ester generates fast serum peaks and drops; EOD administration is the floor for stable concentrations. Clinical picture: rapid lean-tissue accretion independent of caloric surplus, reduced adipose mass via direct AR signalling in adipocytes, pronounced lipid shift (HDL suppression 40–60%). Prolactin elevation occurs in a subset — cabergoline 0.25 mg twice weekly is the standard response. Renal biomarkers (creatinine, cystatin C) commonly shift upward; this reflects haem metabolite excretion in urine (brick-red pigment) rather than confirmed nephrotoxicity, but CKD-EPI readings should be interpreted with the confounding documented. Nocturnal sympathetic tone (insomnia, diaphoresis) is dose-dependent and resolves on cessation.
Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.
We use cookies for essential site functionality and — with your consent — for analytics and marketing. You can accept all, reject non-essential, or configure. Privacy Policy
Reviews
There are no reviews yet.